Plus Therapeutics, Inc. (PSTV) Description, Stock price, News & Info.

#ThinkSabio Latest News

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases in Patients with Lung Cancer